To validate our approach, we tested four well-known tumor drivers: oncogenes Dp110 (officially known as Pi3K92E) and Egfr were overexpressed, and tumor suppressors Pten and Rb were reduced by knockdown in the context of ptc>Myc,p53sh. This evidence concerns the gene EGFR and neoplasm.